Filing Details

Accession Number:
0001179110-13-016712
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-18 18:49:39
Reporting Period:
2013-11-15
Filing Date:
2013-11-18
Accepted Time:
2013-11-18 18:49:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1360886 Osiris Therapeutics Inc. OSIR Biological Products, (No Disgnostic Substances) (2836) 710881115
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398249 Leroux Michelle Williams 7015 Albert Einstein Drive
Columbia MD 21046
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-15 5,750 $0.40 5,750 No 4 M Direct
Common Stock Acquisiton 2013-11-15 7,500 $0.40 13,250 No 4 M Direct
Common Stock Acquisiton 2013-11-15 11,250 $6.46 24,500 No 4 M Direct
Common Stock Disposition 2013-11-15 24,500 $15.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2013-11-15 5,750 $0.40 5,750 $0.40
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-11-15 7,500 $0.40 7,500 $0.40
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-11-15 11,250 $6.46 11,250 $6.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
187,500 2005-11-22 2014-11-22 No 4 M Direct
180,000 2006-12-01 2015-12-01 No 4 M Direct
168,750 2011-05-27 2020-05-27 No 4 M Direct